NEULAND LABS Results Analysis-Q4FY26

$NEULANDLAB Operating Revenue for Q4FY26 is Rs. 776 Crs., 136.4% growth YoY, Total Income is Rs. 789 Crs., 134.86% growth YoY, Gross Profit is Rs. 507 Crs., 151.64% growth YoY, EBITDA is Rs. 320 Crs., 446.29% growth YoY, EBITDA Margin is 40.55% improved by 2312 Basis points YoY, PBT Rs. 287 Crs. 631.53% growth YoY, PAT Rs. 213 Crs. 664.72% growth YoY. Net Debt stood at Rs. (156.8) crore as at Q4FY26 end compared to Rs. (228.7) crore as at Q4FY25 end. CMS “contributing over two thirds of revenue this quarter.” “This exceptional operating margin reflects the record high revenue this quarter, partly… uneven nature of our revenue flows and should not be seen as an indicator of our future performance.” On QoQ basis Op. Revenue is up by 76.54%, Total Income is up by 76.15%, Gross Profit is up by 102.26%, EBITDA is up by 275.44%, PBT is up by 427.7% and PAT is also up by 424.21%.